The 3,000-patient PROTECTED TAVR trial is large enough to detect a clinical reduction in stroke at 72 hours. And the ongoing WATCH-TAVR trial aims to show whether simultaneous TAVR and Watchman placement is safe and cost-saving.
A multicenter group of stroke experts has published guidance for optimizing care for virus-infected individuals while maintaining ideal stroke management and protecting stroke clinicians.
An NIH grant will help Cleveland Clinic researchers determine whether the novel dual-action agent can safely lengthen the thrombolytic time window in ischemic stroke and protect against reperfusion injury.
An expert distills recent findings on how these units are being shown to impact functional outcomes and the cost-effectiveness of care. And he cites studies to keep an eye on in mobile treatment of hemorrhagic stroke.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Several neurologic features are emerging as more common than first recognized. This short review identifies them and discusses the potential neuroinvasiveness of SARS-CoV-2.
The risk of stroke is up to 2.5 times higher in racial and ethnic minorities than in the general population. That’s why we created our Minority Stroke Program to enhance community outreach efforts.
An expert attendee draws from a wealth of presentations to share why a handful of new (and old) studies are likely to change practice in stroke care.
The risk of stroke following confirmed retinal artery occlusion is lower than previously believed, a Cleveland Clinic study suggests. Our researchers discuss the implications and call for similar analyses from other institutions.
Sleep apnea is associated with heart failure, atrial fibrillation, stroke, coronary artery disease and cardiovascular mortality. CPAP treatment may reduce the risk of cardiac events, indicate some data.
With grant funding from the Department of Defense, a team of researchers will test the ability of a new machine learning algorithm to accurately determine the degree of stenosis and predict the precise plaque composition. Dr. Geoffrey Vince discusses the project, which he believes could lead to a new means of clinically assessing stroke risk.